Investment Thesis Shares of Teladoc Health (NYSE: TDOC) have been in a downward trend since February, creating a compelling valuation with shares trading at just 11 times its current sales. My opinion is that the share price drop is only a temporary blip, and that this is a good time to enter into a long-term investment that will yield a CAGR of 20% over the next 10 years. To begin with, the company's top-line has grown tremendously since establishing itself as a one-stop shop platform for all your clinical needs. Moreover, Teledoc's dominance in the market along with their various virtual care offerings has given them an edge that will contribute in the long run to increased shareholder value. Last but not least, you'll find that the company is currently cheaply priced in comparison with other growth-oriented stocks.
Teladoc: The Best Way to Play Virtual Health Care
Teladoc: The Best Way to Play Virtual Health…
Teladoc: The Best Way to Play Virtual Health Care
Investment Thesis Shares of Teladoc Health (NYSE: TDOC) have been in a downward trend since February, creating a compelling valuation with shares trading at just 11 times its current sales. My opinion is that the share price drop is only a temporary blip, and that this is a good time to enter into a long-term investment that will yield a CAGR of 20% over the next 10 years. To begin with, the company's top-line has grown tremendously since establishing itself as a one-stop shop platform for all your clinical needs. Moreover, Teledoc's dominance in the market along with their various virtual care offerings has given them an edge that will contribute in the long run to increased shareholder value. Last but not least, you'll find that the company is currently cheaply priced in comparison with other growth-oriented stocks.